JP2021524273A5 - - Google Patents

Download PDF

Info

Publication number
JP2021524273A5
JP2021524273A5 JP2021500619A JP2021500619A JP2021524273A5 JP 2021524273 A5 JP2021524273 A5 JP 2021524273A5 JP 2021500619 A JP2021500619 A JP 2021500619A JP 2021500619 A JP2021500619 A JP 2021500619A JP 2021524273 A5 JP2021524273 A5 JP 2021524273A5
Authority
JP
Japan
Prior art keywords
norovirus
protein
gii
amino acid
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021500619A
Other languages
English (en)
Japanese (ja)
Other versions
JP7429684B6 (ja
JP7429684B2 (ja
JP2021524273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2018/051529 external-priority patent/WO2020010428A1/en
Publication of JP2021524273A publication Critical patent/JP2021524273A/ja
Publication of JP2021524273A5 publication Critical patent/JP2021524273A5/ja
Application granted granted Critical
Publication of JP7429684B2 publication Critical patent/JP7429684B2/ja
Publication of JP7429684B6 publication Critical patent/JP7429684B6/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021500619A 2018-07-13 2018-11-30 改変ノロウイルスvp1タンパク質および改変ノロウイルスvp1タンパク質を含むvlp Active JP7429684B6 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862697770P 2018-07-13 2018-07-13
US62/697,770 2018-07-13
PCT/CA2018/051529 WO2020010428A1 (en) 2018-07-13 2018-11-30 Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins

Publications (4)

Publication Number Publication Date
JP2021524273A JP2021524273A (ja) 2021-09-13
JP2021524273A5 true JP2021524273A5 (cg-RX-API-DMAC7.html) 2022-01-11
JP7429684B2 JP7429684B2 (ja) 2024-02-08
JP7429684B6 JP7429684B6 (ja) 2024-03-15

Family

ID=69143247

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500619A Active JP7429684B6 (ja) 2018-07-13 2018-11-30 改変ノロウイルスvp1タンパク質および改変ノロウイルスvp1タンパク質を含むvlp

Country Status (5)

Country Link
US (1) US11759512B2 (cg-RX-API-DMAC7.html)
EP (1) EP3821014A4 (cg-RX-API-DMAC7.html)
JP (1) JP7429684B6 (cg-RX-API-DMAC7.html)
CA (1) CA3106471A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020010428A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7153797B2 (ja) * 2018-11-13 2022-10-14 テレフオンアクチーボラゲット エルエム エリクソン(パブル) バインディング情報管理のための方法および装置
WO2025077799A1 (en) * 2023-10-12 2025-04-17 Chengdu Kanghua Biological Products Co., Ltd. Method of preparing norovirus vaccine without adjuvant

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879338B2 (en) * 2003-07-21 2011-02-01 Boyce Thompson Institute For Plant Research Vectors and methods for immunization against norovirus using transgenic plants
EP2601969B1 (en) 2006-09-29 2016-03-30 Takeda Vaccines, Inc. Norovirus vaccine formulations
JP5852883B2 (ja) 2008-08-08 2016-02-03 タケダ ワクチン,インコーポレイテッド 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子
SI3354657T1 (sl) 2009-09-22 2022-05-31 Medicago Inc. Postopek za pripravo iz rastlin izpeljanih beljakovin
CA2804501C (en) 2010-07-06 2021-01-26 Novartis Ag Noro virus derived immunogenic compositions and methods
US9975923B2 (en) * 2013-03-15 2018-05-22 The University Of North Carolina At Chapel Hill Methods and compositions for norovirus blockade epitopes
EP2970395A4 (en) * 2013-03-15 2017-03-29 The University of North Carolina At Chapel Hill Methods and compositions for norovirus blockade epitopes
EP4631970A3 (en) 2016-05-04 2026-01-07 CureVac SE Nucleic acid molecules and uses thereof
EP3601580A4 (en) 2017-03-23 2021-01-06 Medicago Inc. NOROVIRUS FUSION PROTEINS AND VLPS WITH NOROVIRUS FUSION PROTEINS

Similar Documents

Publication Publication Date Title
JP2021503962A5 (cg-RX-API-DMAC7.html)
RU2020116307A (ru) Модифицированные белки vp1 норовируса и vlp, содержащие модифицированные белки vp1 норовируса
JP2019504030A5 (cg-RX-API-DMAC7.html)
CN103627678B (zh) 一种猪伪狂犬病病毒变异株prv-zj01及应用
CN108456663B (zh) 一种1型牛病毒性腹泻病毒样颗粒及其制备与应用
JP2019500320A5 (cg-RX-API-DMAC7.html)
US20220143175A1 (en) Norovirus vaccines
RU2014116371A (ru) Повышение выхода вирусоподобных частиц в растениях
JP2013517773A5 (cg-RX-API-DMAC7.html)
WO2023020737A1 (en) Fmdv virus-like particle with stabilizing mutation
JP2014519817A5 (cg-RX-API-DMAC7.html)
WO2023020738A1 (en) Fmdv virus-like particle with double stabilizing mutation
WO2022084426A1 (en) Baculovirus expression vector
WO2014095956A1 (en) CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE
CN113061587A (zh) 一种抗原谱拓展o型口蹄疫病毒株及其构建方法和应用
RU2010125695A (ru) Гены, кодирующие главный капсидный белок l1 вируса папилломы человека, и их применение
WO2022084438A1 (en) Baculovirus expression vector
RU2019113940A (ru) Мозаичные вакцины от вируса ящура серотипа а
WO2023021167A1 (en) Method of producing a foot and mouth disease virus virus-like particle
KR20210055667A (ko) 부유세포 배양에 적응된 A/ASIA/Sea-97 유전형 구제역 바이러스 백신주 및 이의 제조방법
KR102733183B1 (ko) 중동호흡기증후군 코로나바이러스 및 이의 용도
CN105801704A (zh) 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用
RU2020143526A (ru) Мутанты гемагглютинина вируса гриппа
CN109943536B (zh) 一种戊型肝炎病毒的培养方法及其灭活疫苗的制备方法
RU2020143530A (ru) Мутанты гемагглютинина вируса гриппа